Market Tracker

09/15 6:05pm ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

1.50
Data as of Sep 15
 -0.05 / -3.23%
Today’s Change
1.16
Today|||52-Week Range
3.18
+7.91%
Year-to-Date

Today’s Trading

Previous close1.55
Today’s open1.54
Day’s range1.50 - 1.55
Volume945,922
Average volume (3 months)1,061,702
Market cap$278.2M
Dividend yield--
Data as of 3:59pm ET, 09/15/2014

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)-27.27%
Earnings growth (next 5 years)--
Revenue growth (last year)+3.31%
P/E ratioNM
Price/Sales12.55
Price/Book4.10

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...0.000.00%
SVASinovac Biotech Ltd-0.02-0.40%
AGTCApplied Genetic Tech...-0.63-3.66%
PTXPernix Therapeutics ...-0.26-3.61%
Data as of 3:59pm ET, 09/15/2014

Financials

Last reporting dateSeptember 9, 2014
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$22.4M
Annual profit (last year)-$35.4M
Net profit margin-157.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
Chief Financial Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts